Physician and patient adherence at baseline and 5 months
| Baseline | 5 months | |
|---|---|---|
| Physician full adherence* | N=20 | N=20 |
| ACE-I/ARB, N/total (%) | 9/13 (69.2) | 10/13 (76.9) |
| β-blockers, N/total (%) | 10/10 (100) | 9/10 (90) |
| Aldosterone antagonists, N/total (%) | 2/12 (16.7) | 0/12 (0.0) |
| Patient adherence | N=33 | N=23 |
| Percentage of prescribed drugs taken†, median (Q1, Q3) | 82.6 (76.0, 94.0) | 71.8 (38.3, 79.8) |
| Participants ≥80% adherent†, N (%) | 10 (43.5) | 4 (17.4) |
| Full adherence by MMAS‡, N (%) | 9 (39.1) | 15 (65.2) |
| Sodium intake (mg), median (Q1, Q3)§ | 3464 (2400, 4125) | 2036.5 (1800, 2384) |
*Calculated only for those patients in whom the medication was indicated at baseline and at 5 months.
†Using electronic pill caps N=23.
‡ MMAS (0–4, where 4 indicates full adherence).
§p<0.01.
ACE-I, ACE inhibitor; ARB, angiotensin receptor blocker; MMAS, Morisky Medication Adherence Scale.